Cargando…
Isodeoxyelephantopin Inactivates Thioredoxin Reductase 1 and Activates ROS-Mediated JNK Signaling Pathway to Exacerbate Cisplatin Effectiveness in Human Colon Cancer Cells
Colon cancer is one of the leading causes of cancer-related death in the world. The development of new drugs and therapeutic strategies for patients with colon cancer are urgently needed. Isodeoxyelephantopin (ESI), a sesquiterpene lactone isolated from the medicinal plant Elephantopus scaber L., ha...
Autores principales: | Hong, Lin, Chen, Jundixia, Wu, Fang, Wu, Fengjiao, Shen, Xin, Zheng, Peisen, Shao, Rongrong, Lu, Kongqin, Liu, Zhiguo, Chen, Daoxing, Liang, Guang, Cai, Yuepiao, Zou, Peng, Xia, Yiqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536313/ https://www.ncbi.nlm.nih.gov/pubmed/33072762 http://dx.doi.org/10.3389/fcell.2020.580517 |
Ejemplares similares
-
EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells
por: Zou, Peng, et al.
Publicado: (2016) -
Deoxyelephantopin and Isodeoxyelephantopin as Potential Anticancer Agents with Effects on Multiple Signaling Pathways
por: Mehmood, Tahir, et al.
Publicado: (2017) -
Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress
por: Zhang, Tingting, et al.
Publicado: (2022) -
Thioredoxin Reductase and its Inhibitors
por: Saccoccia, Fulvio, et al.
Publicado: (2014) -
Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors
por: Xia, Yiqun, et al.
Publicado: (2021)